Storia in 2 fonti

LongBio Pharma closes IPO offering

LongBio Pharma closed its Hong Kong IPO on June 2 with a 4,470-fold oversubscription, setting a recent market record. The clinical-stage company, whic…

Raccontata da

kr-asia.com

morningstar.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

kr-asia.comStai leggendo2 mesi fa

LongBio Pharma closes IPO offering

LongBio Pharma closed its Hong Kong IPO on June 2 with a 4,470-fold oversubscription, setting a recent market record. The clinical-stage company, whic…

originale

morningstar.com2 mesi fa

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong…

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

Leggi questa versione → originale

Timeline cronologica

giovedì 4 giugno 2026·kr-asia.com
LongBio Pharma closes IPO offering
LongBio Pharma closed its Hong Kong IPO on June 2 with a 4,470-fold oversubscription, setting a recent market record. The clinical-stage company, whic…
venerdì 5 giugno 2026·morningstar.com
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange